相似文献
1
Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.
Cell Cycle. 2013 May 15;12(10):1637-8. doi: 10.4161/cc.24662. Epub 2013 Apr 19.
2
Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Science. 2015 Feb 27;347(6225):1006-10. doi: 10.1126/science.1260200. Epub 2015 Feb 5.
3
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Eur Urol. 2014 Feb;65(2):360-6. doi: 10.1016/j.eururo.2013.08.052. Epub 2013 Sep 7.
4
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17426-31. doi: 10.1073/pnas.1310522110. Epub 2013 Oct 7.
5
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.
Int J Mol Sci. 2022 Sep 16;23(18):10819. doi: 10.3390/ijms231810819.
6
Activating Telomerase Promoter Mutations and Their Application for the Detection of Bladder Cancer.
Int J Mol Sci. 2020 Aug 21;21(17):6034. doi: 10.3390/ijms21176034.
7
Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.
Ann Diagn Pathol. 2015 Oct;19(5):301-5. doi: 10.1016/j.anndiagpath.2015.06.007. Epub 2015 Jun 16.
8
Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Nat Rev Urol. 2018 Jun;15(6):386-393. doi: 10.1038/s41585-018-0001-5.
9
Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma.
Eur Urol Focus. 2018 Dec;4(6):880-888. doi: 10.1016/j.euf.2017.03.007. Epub 2017 Mar 31.
10
Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Histopathology. 2016 Jul;69(1):107-13. doi: 10.1111/his.12920. Epub 2016 Feb 11.
引用本文的文献
1
A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population.
Sci Rep. 2025 Apr 24;15(1):14346. doi: 10.1038/s41598-025-96929-0.
2
Aging, Cancer, and Inflammation: The Telomerase Connection.
Int J Mol Sci. 2024 Aug 5;25(15):8542. doi: 10.3390/ijms25158542.
3
Prognostic Impact of Promoter Mutations in Adult-Type Diffuse Gliomas Based on WHO2021 Criteria.
Cancers (Basel). 2024 May 27;16(11):2032. doi: 10.3390/cancers16112032.
4
TERTmonitor-qPCR Detection of Mutations in Glioma.
Genes (Basel). 2023 Aug 25;14(9):1693. doi: 10.3390/genes14091693.
5
The sex gap in bladder cancer survival - a missing link in bladder cancer care?
Nat Rev Urol. 2024 Mar;21(3):181-192. doi: 10.1038/s41585-023-00806-2. Epub 2023 Aug 21.
6
Genomic Landscape of Meningiomas.
Adv Exp Med Biol. 2023;1416:137-158. doi: 10.1007/978-3-031-29750-2_11.
7
TERT Promoter Mutation in Benign and Malignant Salivary Gland Tumors; A Cross-Sectional Study.
Iran J Pathol. 2023;18(1):64-74. doi: 10.30699/IJP.ijp.2023.556651.2927. Epub 2023 Mar 23.
8
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.
Biomedicines. 2023 Feb 24;11(3):691. doi: 10.3390/biomedicines11030691.
9
promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance.
Front Immunol. 2023 Jan 12;13:1071390. doi: 10.3389/fimmu.2022.1071390. eCollection 2022.
10
Integrated Analysis of Altered lncRNA, circRNA, microRNA, and mRNA Expression in Hepatocellular Carcinoma Carrying TERT Promoter Mutations.
J Hepatocell Carcinoma. 2022 Nov 29;9:1201-1215. doi: 10.2147/JHC.S385026. eCollection 2022.
本文引用的文献
1
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6. doi: 10.1073/pnas.1303607110. Epub 2013 Mar 25.
2
Highly recurrent TERT promoter mutations in human melanoma.
Science. 2013 Feb 22;339(6122):957-9. doi: 10.1126/science.1229259. Epub 2013 Jan 24.
3
TERT promoter mutations in familial and sporadic melanoma.
Science. 2013 Feb 22;339(6122):959-61. doi: 10.1126/science.1230062. Epub 2013 Jan 24.
4
Telomerase and the search for the end of cancer.
Trends Mol Med. 2013 Feb;19(2):125-33. doi: 10.1016/j.molmed.2012.11.006. Epub 2012 Dec 17.
5
Telomerase RNA biosynthesis and processing.
Biochemistry (Mosc). 2012 Oct;77(10):1120-8. doi: 10.1134/S0006297912100045.
Zotero 插件